Author, year | N | Inclusion criteria age range (yrs) | Mean age (yrs) CB group | Mean age (yrs) PB group | Mean weight (kg) CB group | Mean weight (kg) PB group | Medication dose CB group | Medication dose PB group | Time to 1st additive analgesia (min) CB group (mean ± SD) | Time to 1st additive analgesia (min) PB group (mean ± SD) | F/U (hrs) |
Yeoman et al., 1983 | 38 | 1.5 to 12 | 6.25 ± 3.2 | 6.5 ± 3.2 | 22.3 | 23.2 | 0.5% bupivacaine (1 mL/yr + 2 mL) | 0.5% bupivacaine (1 mL/3yr) | - | - | 7 |
Vater & Wandless, 1985 | 50 | 1 to 13 | 5.6 ± 3.4 | 4.6 ± 2.9 | 20.3 ± 7.3 | 18.1 ± 6.2 | 0.25% bupivacaine (0.5 mL/kg) | 0.5% bupivacaine (1-5 yrs - 3 mL; 6-12 yrs - 4 mL) | 313 ± 183.3 | 256.4 ± 177.6 | 24 |
Irwin & Chang, 1996 | 50 | 2 to 12 | 5.1 ± 2.1 | 6.4 ± 2.9 | 18.9 ± 5.9 | 22.3 ± 9.4 | 0.25% bupivacaine (0.75 mL/kg) | 0.5% bupivacaine (1-2 mL) | - | - | 24 |
Mak et al., 2001 | 126 | 1 to 12 | 6.5 ± 2.9 | 6.5 ± 3.0 | 24.6 ± 9.4 | 23.3 ± 8.0 | 0.25% bupivacaine (0.5 mL/kg) | 0.5% bupivacaine (<15 kg - 2 mL; 15 - 24 kg - 2.5 mL; 25 - 30 kg - 3 mL; 31 - 40 kg - 3.5 mL; >40 kg - 4 mL) | 354 ± 143.8 | 366 ± 173.2 | 96 |
Gautlett, 2003 | 60 | 1 to 10 | 5.09 ± 2.32 | 5.47 ± 2.43 | 20.9 ± 6.0 | 22.1 ± 6.9 | 0.15% bupivacaine (0.5 mL/kg), ketamine (0.5 mg/kg) | 0.5% bupivacaine (3 - 5 mL by age + 1 mL subQ) | - | - | 24 |
Weksler et al., 2005 | 100 | 3 to 8 | 5 ± 2 | 5 ± 2 | 20 ± 4 | 20 ± 4 | 0.25% bupivacaine (1 mL/kg) | 0.5% bupivacaine (0.3 mL/kg) | - | - | 24 |
Margetts et al., 2008 | 40 | 1.5 to 16 | 7.8 ± 1.7 | 7.9 ± 1.3 | - | - | 0.25% bupivacaine (0.5 mL/kg), ketamine (0.5 mg/kg) | 0.5% bupivacaine (0.25 mL/kg) | 485.8 ± 124.9 | 361.3 ± 183.1 | 24 |
Beyaz, 2011 | 50 | 3 to 12 | 7.4 ± 3.1 | 8.5 ± 3.5 | 23.4 ± 8.6 | 29.4 ±11.3 | 0.25% levo-bupivacaine (0.5 mL/kg) | 0.25% levo-bupivacaine (0.5 mL/kg) | 354 ± 15 | 352 ± 18 | 6 |
Kazak et al., 2012 | 60 | 2 to 10 | 6 ± 3 | 7 ± 2 | 23 ± 9 | 26 ± 6 | 0.25% levo-bupivacaine (1 mg/kg) | 0.25% levo-bupivacaine (1 mg/kg) | 458 ± 73 | 376 ± 68 | 24 |